• November 16, 2025
  • See all results
MedShadow Trademarked LogoBalancing the Risks and Benefits of Medications
DONATE Newsletter WEBINARS
  • ABOUT
    • About MedShadow
    • Our Team
    • Foundation Board
    • Health and Medical Advisory Panel
    • Podcast
    • MedShadow In The News
  • ARTICLES
    woman receiving intravenous infusion

    FDA SIDE EFFECTS UPDATE: New Liver Injury Warnings for MS Drugs and Epilepsy Treatment

    Pharmacist talking to family

    When the Neighborhood Pharmacy Closes, ‘Everything Changes’

    Flaws in the U.S. Opioid Supply Chain

    INVESTIGATING GENERICS: Decades of Recalls Reveal Flaws in the U.S. Opioid Supply Chain 

    Blood Pressure Meds Tainted With Cancer-Causing Chemicals

    FDA Drug Recalls and Warnings: Blood Pressure Meds Tainted With Cancer-Causing Chemicals, Gabapentin Impurities and More

    • New Articles
    • Health Topics
    • Conditions
    • Medications
    • Wellness
    • Culture Desk
  • VIDEOS
    VIDEOS
    woman receiving intravenous infusion

    FDA SIDE EFFECTS UPDATE: New Liver Injury Warnings for MS Drugs and Epilepsy Treatment

    Pharmacist talking to family

    When the Neighborhood Pharmacy Closes, ‘Everything Changes’

    Flaws in the U.S. Opioid Supply Chain

    INVESTIGATING GENERICS: Decades of Recalls Reveal Flaws in the U.S. Opioid Supply Chain 

    Blood Pressure Meds Tainted With Cancer-Causing Chemicals

    FDA Drug Recalls and Warnings: Blood Pressure Meds Tainted With Cancer-Causing Chemicals, Gabapentin Impurities and More

    Man dealing with insomnia, treatment CBT-1

    A Safer Way to Tame Insomnia

    • Medical Animation Videos
    • Patient Story Videos
    • Nutrition Videos
  • PODCAST
    PODCAST

    Preventable Illnesses: Lifestyle Choices Over Medication

    Childhood Asthma and Obesity: The Road to Resilience

    Childhood Asthma and Obesity: The Road to Resilience

    Food As Fuel: Managing Sugar Cravings to Fight Inflammation

    Food As Fuel: Managing Sugar Cravings to Fight Inflammation

    Creativity in Veganism, and Discovering Vegan Life Balance

    Creativity in Veganism, and Discovering Vegan Life Balance

    Preventative Senior Fitness, Super-Agers, and Trusting Your Body

    Preventative Senior Fitness, Super-Agers, and Trusting Your Body

  • INFOGRAPHICS
  • Login / Signup
  • Search
Home
Features
FDA Watch
Random
  • Latest
  • Oldest
  • Random
  • A to Z

FDA Watch

Issues Related to HealthcareFDA Watch

Congress Protects Healthcare — For Now

Jonathan Block
Heart Failure Drug Rejected, Rejected Again, Then Approved, What’s Up?
FDA Watch

Is the FDA Really That Slow at Approving Drugs?

Jonathan Block
Why School Shootings Are As Much Public Health Issues As They Are Gun Control Ones
Healthy Skeptic 2

Why School Shootings Are As Much Public Health Issues As They Are Gun Control Ones

Jonathan Block
FDA Updates Chantix Label to Include Potential Alcohol Interaction
FDA

FDA Updates Chantix Label to Include Potential Alcohol Interaction

Alanna McCatty
FDA Requiring Long-Term Research of OxyContin Use
Opioid News

FDA Requiring Long-Term Research of OxyContin Use

Suzanne B. Robotti
Scott Gottlieb’s Potential Impact on the FDA as Commissioner
FDA Watch

Scott Gottlieb’s Potential Impact on the FDA as Commissioner

Steven Findlay
Did Hype Drive the FDA Decision on Addyi (Flibanserin)?
FDA Watch

Did Hype Drive the FDA Decision on Addyi (Flibanserin)?

Sarah Smedley
Restasis: When Advertising Outweighs Research and Common Sense
Healthy Skeptic 2

Restasis: When Advertising Outweighs Research and Common Sense

Suzanne B. Robotti
covid vaccines off-label
Issues Related to HealthcareFDA WatchFDA

FDA May Loosen Rules on Off-Label Drug Use

Sarah Smedley
Patient Advocacy Groups: Help or Hindrance to FDA Approval?
FDA

Patient Advocacy Groups: Help or Hindrance to FDA Approval?

Jonathan Block
FDA
FDA

Rare Peek Into Internal FDA Furor: ARBs

Medshadow Staff
E-Cigarettes Now On FDA’s Radar
E-Cigarette News

E-Cigarettes Now On FDA’s Radar

Sarah Smedley
Suicide and Mental Illness: Crises in America
Mental Health

Suicide and Mental Illness: Crises in America

Jonathan Block
EpiPen And The Problem With Unbranded Pharma Ads
FDA Watch

EpiPen And The Problem With Unbranded Pharma Ads

Jonathan Block
MedShadow's Top 10 Stories of 2018 (FDA)
MedShadow Articles

MedShadow’s Top 10 Stories of 2018 (FDA)

Jonathan Block
Many Clinical Trials Often Absent From Journals
News

Many Clinical Trials Often Absent From Journals

Alanna McCatty
FDA Again Delays Rule on New Safety Warnings for Generic Labels
FDA

FDA Again Delays Rule on New Safety Warnings for Generic Labels

Jonathan Block
Issues Related to HealthcareTests and TestingFDA WatchTreatments

What Happens When an Drug with Approval Isn’t That Effective?

Jonathan Block
Breast Cancer Patients To FDA: We Need Options
Breast Cancer

Breast Cancer Patients To FDA: We Need Options

Sarah Smedley
Is Kratom Really As Dangerous As the FDA Makes It Out to Be?
Anxiety and DepressionFDA Watch

Is Kratom Really As Dangerous As The FDA Makes It Out To Be?

Jonathan Block
Load More

ABOUT MEDSHADOW

Medications have many benefits, but it’s essential to know how to balance these against their potential side effects. MedShadow is a nonprofit foundation that focuses on the safest ways to take over-the-counter (OTC) and prescription (Rx) medications. Our name derives from the fact that side effects can sometimes be difficult to recognize, which is why we work to illuminate and explain medication reactions that may be minimized or obscured.

We also help people factor in integrative health and medicine options and provide information about lifestyle changes to optimize one’s health. Whatever decision a person makes, our goal is to be supportive.

At MedShadow, our mission is to provide independent, evidence-and science-based information. Our service and investigative journalism enables people to make informed decisions and we strive to stimulate public conversation aimed at reforming the drug manufacturing processes to ensure that we are all better protected.

We do not receive any financial support from the pharmaceutical or supplement industries and we require that all our staff, writers, advisors and other partners also be free from any remunerative relationships with such companies.

SERVICES

  • ACCOUNT
    • Become an Insider
    • Login
  • ABOUT
    • About MedShadow
    • Our Team
    • Foundation Board
    • Medical Advisors
    • Writers
    • MedShadow In The News
  • ARTICLES
    • New Articles
    • Health Topics
    • Conditions
    • Medications
    • Wellness
    • Culture Desk
  • PODCAST
  • VIDEOS
  • INFOGRAPHICS
  • CONTACT US
Balancing the Risks and Benefits of Medications
Copyright © 2025, MedShadow Foundation. All rights reserved. MedShadow Foundation is a registered 501(c)(3) non-profit organization. MedShadow does not accept advertising or contributions from pharmaceutical companies, medical device manufacturers or political action organizations. This site complies with the HONcode standard for trustworthy health information.
  • TERMS
  • ABOUT
    • About MedShadow
    • Our Team
    • Foundation Board
    • Health and Medical Advisory Panel
    • Podcast
    • MedShadow In The News
  • ARTICLES
    • New Articles
    • Health Topics
    • Conditions
    • Medications
    • Wellness
    • Culture Desk
  • VIDEOS
    • Medical Animation Videos
    • Patient Story Videos
    • Nutrition Videos
  • PODCAST
  • INFOGRAPHICS
DONATENewsletter WEBINARS
JOINNewsletter WEBINARS
Start typing to see results or hit ESC to close
Zyrtec PBMs pharmacies Zyvox peer review process
See all results
Username
Password
Lost password?
Create an account
Enter username or email
Cancel
x

Webinar Popup

WEBINAR #1 OF A SERIES      JUNE 25, 4:00-5:30 PM ET

Investigating Generic Drugs: How Poor Quality Generics Cause Harm

REGISTER NOW

  • Katherine EbanJournalist and Author,
    Bottle of Lies
  • David LightCo-founder and President,
    Valisure
  • Joe GraedonPresident,
    The People’s Pharmacy
  • Suzanne Robotti,Founder and President,
    MedShadow Foundation

link

x

Webinar #2